|
|
||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 273, Issue 4 1339-R1345, Copyright © 1997 by American Physiological Society
ARTICLES |
G. Geng, R. Gaspo, F. Trabelsi and N. Yamaguchi
Group de Recherche sur le Systeme Nerveux Autonome, Faculte de Pharmacie, Universite de Montreal, Quebec, Canada.
The aim of the present study was to investigate whether the dihydropyridine-sensitive L-type Ca2+ channel is operative in adrenal catecholamine (CA) secretion induced by a novel neuropeptide, pituitary adenylate cyclase-activating polypeptide (PACAP), in anesthetized dogs. Plasma CA concentrations in adrenal venous and aortic blood were determined by a high-performance liquid chromatography method. All drugs tested were locally infused into the left adrenal gland via the left adrenolumbar artery. PACAP, with the isoform consisting of 27 (PACAP-27) and 38 (PACAP-38) amino acid residues, significantly increased CA output in a dose-dependent manner, with doses ranging from 5 to 500 ng and 7 to 700 ng, respectively. However, the amplitude of epinephrine response to PACAP-27 was three times greater than that obtained with PACAP-38 at the highest dose tested. In a separate group, a single dose of PACAP-27 (50 ng) induced highly reproducible CA responses when the same dose was repeated with an interval of 35 min. In dogs treated with nifedipine (50 microg), 5 min before the second administration of PACAP-27, the net CA response was significantly inhibited by approximately 50% compared with that obtained in the presence of vehicle. A similar CA response to BAY K 8644 (5 microg) was completely abolished by the same dose of nifedipine. The present results indicate that both PACAP-27 and PACAP-38 have the direct local secretagogue effect on the adrenal medulla in vivo and that CA responses to PACAP-27 were greater than those observed with PACAP-38 at equivalent mole doses. The study suggests that the dihydropyridine-sensitive L-type Ca2+ channel is functionally involved in PACAP-induced adrenal CA secretion in the canine adrenal medulla in vivo.
This article has been cited by other articles:
![]() |
S. Lamouche and N. Yamaguchi PACAP release from the canine adrenal gland in vivo: its functional role in severe hypotension Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R588 - R597. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Morita, A. Sakakibara, S. Kitayama, K. Kumagai, K. Tanne, and T. Dohi Pituitary Adenylate Cyclase-Activating Polypeptide Induces a Sustained Increase in Intracellular Free Ca2+ Concentration and Catecholamine Release by Activating Ca2+ Influx via Receptor-Stimulated Ca2+ Entry, Independent of Store-Operated Ca2+ Channels, and Voltage-Dependent Ca2+ Channels in Bovine Adrenal Medullary Chromaffin Cells J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 972 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Fukushima, H. Hikichi, K. Mizukami, T. Nagayama, M. Yoshida, M. Suzuki-Kusaba, H. Hisa, T. Kimura, and S. Satoh Role of endogenous PACAP in catecholamine secretion from the rat adrenal gland Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1562 - R1567. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hirose, Z. Leatmanoratn, K. R. Laurita, and M. D. Carlson Effects of pituitary adenylate cyclase-activating polypeptide on canine atrial electrophysiology Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1667 - H1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Fukushima, T. Nagayama, H. Kawashima, H. Hikichi, M. Yoshida, M. Suzuki-Kusaba, H. Hisa, T. Kimura, and S. Satoh Role of calcium channels and adenylate cyclase in the PACAP-induced adrenal catecholamine secretion Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R495 - R501. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lamouche and N. Yamaguchi Role of PAC1 receptor in adrenal catecholamine secretion induced by PACAP and VIP in vivo Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2001; 280(2): R510 - R518. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vaudry, B. J. Gonzalez, M. Basille, L. Yon, A. Fournier, and H. Vaudry Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: From Structure to Functions Pharmacol. Rev., June 1, 2000; 52(2): 269 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zeng, C. Athmann, T. Kang, J. H. Walsh, and G. Sachs Role of neuropeptide-sensitive L-type Ca2+ channels in histamine release in gastric enterochromaffin-like cells Am J Physiol Gastrointest Liver Physiol, December 1, 1999; 277(6): G1268 - G1280. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lamouche, D. Martineau, and N. Yamaguchi Modulation of adrenal catecholamine release by PACAP in vivo Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1999; 276(1): R162 - R170. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. N. Osipenko, A. P. Barrie, J. M. Allen, and A. M. Gurney Pituitary Adenylyl Cyclase-activating Peptide Activates Multiple Intracellular Signaling Pathways to Regulate Ion Channels in PC12 Cells J. Biol. Chem., May 26, 2000; 275(22): 16626 - 16631. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |